Literature DB >> 33946188

Green Propolis Compounds (Baccarin and p-Coumaric Acid) Show Beneficial Effects in Mice for Melanoma Induced by B16f10.

Gabriel H Gastaldello1, Ana Caroline V Cazeloto1, Juliana C Ferreira1, Débora Munhoz Rodrigues2, Jairo Kennup Bastos2, Vanessa L Campo1,2, Karina F Zoccal1, Cristiane Tefé-Silva1.   

Abstract

Background: Cutaneous melanoma is the most aggressive form of skin cancer, with the worst prognosis, and it affects a younger population than most cancers. The high metastatic index, in more advanced stages, and the high aggressiveness decrease the effectiveness of currently used therapies, such as surgical removal, radiotherapy, cryotherapy, and chemotherapy, used alone or in combination. Based on these disadvantages, research focused on alternative medicine offers great potential for therapeutic innovation. Medicinal plants represent a remarkable source of compounds for the treatment of various diseases.
Methods: In this study, we investigated the tumoral behavior of melanoma under treatment with the compounds baccarin and p-coumaric acid, extracted from green propolis, in mice inoculated with B16F10 cells for 26 days.
Results: A significant modulation in the number of inflammatory cells recruited to the tumor region and blood in the groups treated with the compounds was observed. In addition, a significant reduction in the amount of blood vessels and mitosis in the neoplastic area was noticed. Conclusions: Through our research, we confirmed that baccarin and coumaric acid, isolated substances from Brazilian green propolis, have a promising anticarcinogenic potential to be explored for the development of new antitumor agents, adhering to the trend of drugs with greater tolerance and biological effectiveness.

Entities:  

Keywords:  baccarin; cancer therapy; coumaric acid; melanoma; skin cancer

Year:  2021        PMID: 33946188     DOI: 10.3390/medicines8050020

Source DB:  PubMed          Journal:  Medicines (Basel)        ISSN: 2305-6320


  62 in total

Review 1.  Propolis and the immune system: a review.

Authors:  J M Sforcin
Journal:  J Ethnopharmacol       Date:  2007-05-22       Impact factor: 4.360

2.  Immunomodulatory and anti-inflammatory effect of p-coumaric acid, a common dietary polyphenol on experimental inflammation in rats.

Authors:  Samuel Joshua Pragasam; Vijayalakshmi Venkatesan; MahaboobKhan Rasool
Journal:  Inflammation       Date:  2013-02       Impact factor: 4.092

3.  Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden.

Authors:  Brenda K Edwards; Holly L Howe; Lynn A G Ries; Michael J Thun; Harry M Rosenberg; Rosemary Yancik; Phyllis A Wingo; Ahmedin Jemal; Ellen G Feigal
Journal:  Cancer       Date:  2002-05-15       Impact factor: 6.860

Review 4.  Angiogenesis in melanoma.

Authors:  Ganapati H Mahabeleshwar; Tatiana V Byzova
Journal:  Semin Oncol       Date:  2007-12       Impact factor: 4.929

Review 5.  Cell death-based treatments of melanoma:conventional treatments and new therapeutic strategies.

Authors:  Gianfranco Mattia; Rossella Puglisi; Barbara Ascione; Walter Malorni; Alessandra Carè; Paola Matarrese
Journal:  Cell Death Dis       Date:  2018-01-25       Impact factor: 8.469

Review 6.  Tumor Energy Metabolism and Potential of 3-Bromopyruvate as an Inhibitor of Aerobic Glycolysis: Implications in Tumor Treatment.

Authors:  Tengjiao Fan; Guohui Sun; Xiaodong Sun; Lijiao Zhao; Rugang Zhong; Yongzhen Peng
Journal:  Cancers (Basel)       Date:  2019-03-06       Impact factor: 6.639

7.  Pretreatment serum VEGF is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab.

Authors:  Jianda Yuan; Jun Zhou; Zhiwan Dong; Sapna Tandon; Deborah Kuk; Katherine S Panageas; Philip Wong; Xinqi Wu; Jarushka Naidoo; David B Page; Jedd D Wolchok; F Stephen Hodi
Journal:  Cancer Immunol Res       Date:  2014-02       Impact factor: 11.151

8.  Brazilian green propolis modulates inflammation, angiogenesis and fibrogenesis in intraperitoneal implant in mice.

Authors:  Luiza D C Lima; Silvia P Andrade; Paula P Campos; Lucíola S Barcelos; Frederico M Soriani; Sandra A L Moura; Mônica A N D Ferreira
Journal:  BMC Complement Altern Med       Date:  2014-05-29       Impact factor: 3.659

Review 9.  Control of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy?

Authors:  Lih Yin Tan; Carmela Martini; Zvi G Fridlender; Claudine S Bonder; Michael P Brown; Lisa M Ebert
Journal:  Clin Transl Immunology       Date:  2017-03-17

10.  Effects of Propolis and Phenolic Acids on Triple-Negative Breast Cancer Cell Lines: Potential Involvement of Epigenetic Mechanisms.

Authors:  João Henrique Maia Assumpção; Agnes Alessandra Sekijima Takeda; José Maurício Sforcin; Cláudia Aparecida Rainho
Journal:  Molecules       Date:  2020-03-12       Impact factor: 4.411

View more
  3 in total

1.  Portuguese Propolis Antitumoral Activity in Melanoma Involves ROS Production and Induction of Apoptosis.

Authors:  Rafaela Dias Oliveira; Sónia Pires Celeiro; Catarina Barbosa-Matos; Ana Sofia Freitas; Susana M Cardoso; Marta Viana-Pereira; Cristina Almeida-Aguiar; Fátima Baltazar
Journal:  Molecules       Date:  2022-05-31       Impact factor: 4.927

Review 2.  Recent Advances in the Antiproliferative and Proapoptotic Activity of Various Plant Extracts and Constituents against Murine Malignant Melanoma.

Authors:  Daria-Antonia Dumitraș; Sanda Andrei
Journal:  Molecules       Date:  2022-04-17       Impact factor: 4.927

Review 3.  Potential of Kalanchoe pinnata as a Cancer Treatment Adjuvant and an Epigenetic Regulator.

Authors:  Marta Elena Hernández-Caballero; José Alfredo Sierra-Ramírez; Ricardo Villalobos-Valencia; Emmanuel Seseña-Méndez
Journal:  Molecules       Date:  2022-09-29       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.